Marijuana Business Daily staff


Articles by Marijuana Business Daily staff :

Cannabis Women to Watch in 2019

The 22 women selected for Marijuana Business Magazine’s list of Women to Watch in 2019 have crafted companies from the ground up, forged new woman-focused alliances and upended traditional business models as they’ve paved the way in this rapidly evolving cannabis industry.

But these women are alike in another way: In this new year, they are embarking on major undertakings as leaders in a nascent industry that, like the rest of corporate America, is dominated by men in the top jobs.

Cannabis retailers share secrets on how to keep customers coming back

Whether it’s shopping for groceries or cannabis, everybody loves getting a good deal.

That’s why loyalty programs – whether they come from your local grocery store or your neighborhood marijuana dispensary – are an effective way to get customers into the shop and keep them coming back.

Community outreach helping cannabis companies gain edge on rivals, attract customers

Marijuana businesses nationwide are finding they can reap generous rewards from giving back to their local communities.

Being a good corporate citizen can make it easier for marijuana businesses to work with regulators and local officials, stand out from competitors and attract new customers and high-quality employees, according to industry executives and experts on corporate giving.

Awaiting a marijuana business license? It’s possible to defray building rental costs

It can take months for a marijuana business to gain licensing approval from regulators.

The biggest problem facing a company in such a situation is it usually must have the location nailed down before filing an application.

But paying rent on space before having a license in hand can cost a lot of money, unless steps are taken early in the process to minimize costs.

Colorado law will now allow CBD prescriptions

Colorado’s governor has signed into a law a bill to allows physicians to prescribe CBD medicines that have been approved by the U.S. Food and Drug Administration.

The FDA’s ruling is expected in a matter of weeks.